Stevens-Johnson Syndrome Induced by Pembrolizumab in a Lung Cancer Patient.

Haratake, Naoki; Tagawa, Tetsuzo; Hirai, Fumihiko; Toyokawa, Gouji; Miyazaki, Reiko; Maehara, Yoshihiko

Haratake, Naoki; Tagawa, Tetsuzo; Hirai, Fumihiko; Toyokawa, Gouji; Miyazaki, Reiko; Maehara, Yoshihiko.

Afiliación

Haratake N; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Tagawa T; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: tetagawa@yahoo.co.jp.
Hirai F; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Toyokawa G; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Miyazaki R; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Maehara Y; Kyushu Central Hospital, Fukuoka, Japan.

J Thorac Oncol ; 13(11): 1798-1799, 2018 11.

Article en En | MEDLINE | ID: mdl-29885481

Asunto(s)

Anticuerpos Monoclonales Humanizados/efectos adversos; Neoplasias Pulmonares/tratamiento farmacológico; Síndrome de Stevens-Johnson/etiología; Anciano; Anticuerpos Monoclonales Humanizados/farmacología; Humanos; Neoplasias Pulmonares/patología; Masculino; Síndrome de Stevens-Johnson/patología

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Stevens-Johnson / Anticuerpos Monoclonales Humanizados / Neoplasias Pulmonares Límite: Aged / Humans / Male Idioma: En Revista: J Thorac Oncol Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google